AGM/EGMApr 28, 2026, 04:09 PM
TARA to Increase Authorized Shares to 200M at Annual Meeting
AI Summary
Protara Therapeutics, Inc. (TARA) announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 12, 2026. Key proposals include the election of three Class III directors, ratification of Ernst & Young LLP as auditor, and advisory votes on executive compensation and its frequency. The company also seeks approval for an amendment to its 2024 Equity Incentive Plan, an increase in authorized common stock from 100 million to 200 million shares, and an amendment allowing officer exculpation.
Key Highlights
- Annual Meeting of Stockholders to be held virtually on June 12, 2026.
- Proposing election of three Class III directors: Jesse Shefferman, Barry Flannelly, Cynthia Smith.
- Seeking ratification of Ernst & Young LLP as independent auditor for fiscal year 2026.
- Proposing advisory vote on named executive officer compensation.
- Proposing advisory vote on frequency (1, 2, or 3 years) for executive compensation vote.
- Seeking approval for an amendment to the 2024 Equity Incentive Plan.
- Proposing to increase authorized common stock from 100,000,000 to 200,000,000 shares.
- Seeking approval for officer exculpation amendment to certificate of incorporation.
Price Impact
More from TARA